Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

2.

Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease.

Xu L, Ren Z, Chow FE, Tsai R, Liu T, Rizzolio F, Boffo S, Xu Y, Huang S, Lippa CF, Gong Y.

Neural Plast. 2017;2017:3270725. doi: 10.1155/2017/3270725. Epub 2017 Mar 26.

3.

Idiopathic Normal Pressure Hydrocephalus: A Review for General Practitioners.

Nassar BR, Lippa CF.

Gerontol Geriatr Med. 2016 Apr 20;2:2333721416643702. doi: 10.1177/2333721416643702. eCollection 2016 Jan-Dec.

4.

Arguing against the proposed definition changes of PD.

Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP.

Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5.

5.

Medical Insurance Coverage and Alzheimer Disease.

Lippa CF.

JAMA Neurol. 2015 Nov;72(11):1231. doi: 10.1001/jamaneurol.2015.2147. No abstract available.

PMID:
26348001
6.

Dementia With Lew Body: Impacts of Surgery.

Pervin F, Edwards C, Lippa CF.

Am J Alzheimers Dis Other Demen. 2016 Feb;31(1):5-17. doi: 10.1177/1533317515581704. Epub 2015 May 24. Review.

PMID:
26006790
7.

Alzheimer's disease: a financial crisis and the Commonwealth of Pennsylvania.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):117-8. doi: 10.1177/1533317515575941. Review. No abstract available.

PMID:
25801504
8.

Enhancing resourcefulness to improve outcomes in family caregivers and persons with Alzheimer's disease: a pilot randomized trial.

Gonzalez EW, Polansky M, Lippa CF, Gitlin LN, Zauszniewski JA.

Int J Alzheimers Dis. 2014;2014:323478. doi: 10.1155/2014/323478. Epub 2014 Sep 29.

9.

Needs assessments of memory disorder patients.

Bowen KJ, Gonzalez EW, Edwards CY, Lippa CF.

Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):667-72. doi: 10.1177/1533317514534952. Epub 2014 May 22.

PMID:
24851872
10.

A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features.

Nygaard HB, Lippa CF, Mehdi D, Baehring JM.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):433-5. doi: 10.1177/1533317513518653. Epub 2014 Jan 24.

PMID:
24463146
11.

The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition.

Chow F, Gong Y, Lippa CF.

Am J Alzheimers Dis Other Demen. 2014 Jun;29(4):303-10. doi: 10.1177/1533317513518645. Epub 2014 Jan 13. Review.

PMID:
24421411
12.

Potential interventions and other considerations for patients with Alzheimer's disease.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2013 Nov;28(7):658-9. doi: 10.1177/1533317513511885. No abstract available.

PMID:
24234764
13.

Clinical Subtypes of Frontotemporal Dementia.

Ghosh S, Lippa CF.

Am J Alzheimers Dis Other Demen. 2015 Nov;30(7):653-61. doi: 10.1177/1533317513494442. Epub 2013 Jun 29. Review.

PMID:
23813692
14.

Multisensory and other nonpharmaceutical approaches to dementia care.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):5-6. doi: 10.1177/1533317512473998. No abstract available.

PMID:
23423703
16.

Disease modifying drugs targeting β-amyloid.

Ozudogru SN, Lippa CF.

Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):296-300. doi: 10.1177/1533317512452034. Review.

PMID:
22815077
17.

Loss of synaptophysin immunoexpression in primary progressive aphasia.

Lippa CF, Rosso AL.

Am J Alzheimers Dis Other Demen. 2012 Jun;27(4):250-3. doi: 10.1177/1533317512446187. Epub 2012 May 14.

PMID:
22586262
18.

A clinical approach to early-onset inheritable dementia.

Rogers BS, Lippa CF.

Am J Alzheimers Dis Other Demen. 2012 May;27(3):154-61. doi: 10.1177/1533317512444000. Review.

PMID:
22573281
19.

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.

Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton MK, Preza E, Lovestone S, Powell J, Graff-Radford N, Petersen RC, Boeve BF, Lippa CF, Bigio EH, Mackenzie I, Finger E, Kertesz A, Caselli RJ, Gearing M, Juncos JL, Ghetti B, Spina S, Bordelon YM, Tourtellotte WW, Frosch MP, Vonsattel JP, Zarow C, Beach TG, Albin RL, Lieberman AP, Lee VM, Trojanowski JQ, Van Deerlin VM, Bird TD, Galasko DR, Masliah E, White CL, Troncoso JC, Hannequin D, Boxer AL, Geschwind MD, Kumar S, Mandelkow EM, Wszolek ZK, Uitti RJ, Dickson DW, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA; Alzheimer's Disease Genetics Consortium, Ross OA, Rademakers R, Schellenberg GD, Miller BL, Mandelkow E, Geschwind DH.

Hum Mol Genet. 2012 Aug 1;21(15):3500-12. doi: 10.1093/hmg/dds161. Epub 2012 May 3.

20.

Apathy and aggression: the management of behavioral features in the dementia population.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2012 Mar;27(2):89. doi: 10.1177/1533317512443406. No abstract available.

PMID:
22495335
21.

Family caregivers at risk: who are they?

Gonzalez EW, Polansky M, Lippa CF, Walker D, Feng D.

Issues Ment Health Nurs. 2011;32(8):528-36. doi: 10.3109/01612840.2011.573123.

PMID:
21767255
22.

Review of issue: caregiver depression and a plan to manage resistance to care.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2011 Jun;26(4):271-2. doi: 10.1177/1533317511412695. Review. No abstract available.

PMID:
21742703
23.

Uplifting news for frontotemporal dementia: The sagging brain syndrome.

Lippa CF, Grossman M.

Neurology. 2011 Apr 19;76(16):1370-1. doi: 10.1212/WNL.0b013e3182167175. No abstract available.

PMID:
21502594
24.

Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration.

Irwin D, Lippa CF, Rosso A.

Am J Alzheimers Dis Other Demen. 2010 Nov;25(7):566-71. doi: 10.1177/1533317510382285.

PMID:
20930186
25.

Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias.

Gong Y, Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 Nov;25(7):547-55. doi: 10.1177/1533317510382893. Epub 2010 Sep 21. Review.

26.

Review of issue: the impact of time of day, mood, and caregiver stress on function in patients with dementia.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 Sep;25(6):475-6. doi: 10.1177/1533317510382487. No abstract available.

PMID:
20819902
27.

Review of issue: cognitive impairment in Parkinson's disease.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):387-8. doi: 10.1177/1533317510374052. No abstract available.

PMID:
20660516
28.

Tarot decks and PET scans: predicting the future of MCI.

Lippa CF, Chetelat G.

Neurology. 2010 Jul 20;75(3):204-5. doi: 10.1212/WNL.0b013e3181e8e91b. Epub 2010 Jun 30. No abstract available.

PMID:
20592256
29.

Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.

Skorobogatko YV, Deuso J, Adolf-Bryfogle J, Nowak MG, Gong Y, Lippa CF, Vosseller K.

Amino Acids. 2011 Mar;40(3):765-79. doi: 10.1007/s00726-010-0645-9. Epub 2010 Jun 19. Erratum in: Amino Acids. 2012 Jun;42(6):2529. Adolf-Bergfoyle, Jared [corrected to Adolf-Bryfogle, Jared].

PMID:
20563614
30.

Lewy body dementia: caregiver burden and unmet needs.

Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):177-81. doi: 10.1097/WAD.0b013e3181c72b5d.

31.

Review of issue: changing environment and activities for the patients with dementia: what can we do to ease the burden?

Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 May;25(3):187-8. doi: 10.1177/1533317510366523. No abstract available.

PMID:
20439920
32.

Lewy body dementia: the caregiver experience of clinical care.

Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH.

Parkinsonism Relat Disord. 2010 Jul;16(6):388-92. doi: 10.1016/j.parkreldis.2010.03.007.

33.

Interventions and diagnostics in Alzheimer's disease and related conditions.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):107-8. No abstract available.

PMID:
20229623
34.

Focusing on the caregiver: grief in dementia caregiving.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 Feb;25(1):7-8. No abstract available.

PMID:
20183890
35.

Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome.

Lippa CF, Rosso AL, Stutzbach LD, Neumann M, Lee VM, Trojanowski JQ.

Arch Neurol. 2009 Dec;66(12):1483-8. doi: 10.1001/archneurol.2009.277.

36.

Barriers to hospice in patients with Alzheimer.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Dec-2010 Jan;24(6):443-4. No abstract available.

PMID:
19938321
37.

Primary progressive aphasia and caregiver issues.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):371-2. No abstract available.

PMID:
19810201
38.

Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier.

Gliebus G, Rosso A, Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Dec-2010 Jan;24(6):456-60. doi: 10.1177/1533317509346209. Epub 2009 Sep 23.

PMID:
19776335
39.

The media and cognitive health in our aging population.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Aug-Sep;24(4):291-292. No abstract available.

PMID:
19658201
40.

Compensating for Alzheimer lesions: evidence that size counts.

Lippa CF.

Neurology. 2009 Sep 1;73(9):656-7. doi: 10.1212/WNL.0b013e3181b61b4c. Epub 2009 Jul 29. No abstract available.

PMID:
19641170
41.

Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease.

Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL.

Brain Res. 2009 Oct 6;1292:191-8. doi: 10.1016/j.brainres.2009.07.056. Epub 2009 Jul 25.

42.

Strategies for patient diagnosis and management.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Jun-Jul;24(3):183-4. No abstract available.

PMID:
19634204
43.

Cerebrospinal immunoglobulin level changes and clinical response to treatment of Hashimoto's encephalopathy.

Gliebus G, Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):373-6. doi: 10.1177/1533317509339162. Epub 2009 Jun 26.

PMID:
19561326
44.

Lewy body dementia.

Hanson JC, Lippa CF.

Int Rev Neurobiol. 2009;84:215-28. doi: 10.1016/S0074-7742(09)00411-5. Review.

PMID:
19501720
45.

Clinical characterization in Alzheimer disease.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2009 Apr-May;24(2):83-4. No abstract available.

PMID:
19455731
46.

Caffeine: neuroprotective functions in cognition and Alzheimer's disease.

Rosso A, Mossey J, Lippa CF.

Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):417-22. Review.

PMID:
19230121
47.

Caffeine, ethical and practical challenges, and nonpharmaceutical interventions for Alzheimer's and related dementias.

Lippa CF.

Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):415-6. No abstract available.

PMID:
19230120
48.

Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities.

Revuelta GJ, Lippa CF.

Int Psychogeriatr. 2009 Apr;21(2):213-6. doi: 10.1017/S1041610208008600. Epub 2009 Jan 28. No abstract available.

PMID:
19173761
49.

Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report.

Irwin D, Revuelta G, Lippa CF.

J Neurol Sci. 2009 Feb 15;277(1-2):164-6. doi: 10.1016/j.jns.2008.10.005. Epub 2008 Nov 17.

PMID:
19013587
50.

Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment.

Lippa CF, Rosso A, Hepler M, Jenssen S, Pillai J, Irwin D.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):149-54. doi: 10.1177/1533317508325095. Epub 2008 Nov 10.

PMID:
19001351

Supplemental Content

Loading ...
Support Center